Wegovy doses and prices: what private treatment costs in the UK

What NICE and the MHRA say about the doses, and why that anchors the price

Wegovy's pricing structure follows its dose ladder. Semaglutide for weight management starts at 0.25 mg weekly and titrates upward (typically in four-weekly steps) through 0.5, 1.0, 1.7 and 2.4 mg, with the newly approved 7.2 mg as the maximum maintenance dose. NICE recommended semaglutide for weight management under TA875, and the MHRA approved the dedicated single-dose 7.2 mg pen on 14 April 2026. Because each dose step uses a different pen configuration, private providers price by the pen you receive that month. Lower doses cost less; the higher maintenance doses cost more. That graduation is one reason a monthly price quoted without specifying the dose is almost meaningless, and worth querying before you hand over any payment.

In the STEP 1 trial, published in the New England Journal of Medicine, participants on semaglutide 2.4 mg lost around 15% of their body weight on average over 68 weeks alongside lifestyle changes. The 7.2 mg dose produced around 20.7% average loss in later trials, bringing results closer to those seen with tirzepatide. Neither figure is a guarantee, and both assume consistent use alongside diet and activity changes. For a fuller comparison of the evidence, the weight-loss treatment overview sets it out clearly.

What headline Wegovy prices usually leave out

Private market prices for Wegovy (reported as roughly £149 to £375 per month depending on dose and provider) are not always straightforward. Some figures are for the pen alone; the consultation fee, prescription charge and delivery cost appear separately at checkout. A few providers charge a monthly membership on top. Aftercare, meaning clinical support between deliveries, is sometimes an optional extra rather than standard. None of that is hidden in the small print of every provider, but it is common enough that the final figure regularly surprises people. Worth checking line by line before you commit.

The per-pen cost breakdown is one place to read about how each dose is packaged and priced. If you are already on treatment elsewhere and thinking about switching, you can find a full explanation of how Wegovy doses relate to overall cost useful too. The broader point is that a low headline number and a genuinely complete service rarely coexist, and when a price looks unusually low, it is worth asking what is not included.

What nume (sorry, what nume charges and why it is deliberate

At nume) at nume, one price covers the clinical consultation, the prescription, the treatment, and next-working-day DPD delivery in a plain box. There are no subscription fees and no auto-renewals; every repeat order is reviewed afresh by a GPhC-registered prescriber. That review is not a formality. A real clinician reads your answers and evidence before the next pen ships. Current treatment pricing is shown on the weight-loss treatments page rather than in this article, because the right dose for you is a clinical decision made at consultation, and quoting a price for a dose you have not yet been assessed for would put the cart before the horse.

We are not the cheapest option in the market. That is a deliberate choice. The price we charge covers a complete service, not a pen in a padded envelope. Our prescribers are listed on the clinical team page and you can verify our pharmacy registration (GPhC premises number 9012878) on the GPhC register. Order before midday on a working day and, once clinically approved, your pen is dispatched the same day.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has warned repeatedly about fake weight-loss pens sold online without a prescription, some seized by enforcement teams contained insulin rather than semaglutide. If you want to understand how Wegovy doses affect the price you pay from a legitimate, regulated UK pharmacy, it helps to read about what each Wegovy dose costs at different points in the titration schedule, and to check how Wegovy prices compare across the full course of treatment before committing to a provider. Discount codes for prescription medicines from sources you cannot verify on the GPhC register are a red flag, not a saving. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets you report any suspect seller.

For a prescription medicine, price is simply the wrong primary filter. The question that protects you is whether the pharmacy is GPhC-registered, whether a qualified prescriber reviewed your case, and whether the supply chain is licensed in the UK. If you have questions before starting, the FAQs cover the most common ones, or you can reach the team through the contact page. The right place to start is a free clinical consultation, not a price comparison.